-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 OnHz7mJmbGRHt6lUL0C1s1cN0Eu53GWathM1Ez8OhGM6/NMOHR3jPhirltWtOlzp
 UYu5lhYBcjUXUlINzPeTSw==

<SEC-DOCUMENT>0001209191-09-028701.txt : 20090526
<SEC-HEADER>0001209191-09-028701.hdr.sgml : 20090525
<ACCEPTANCE-DATETIME>20090526154303
ACCESSION NUMBER:		0001209191-09-028701
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20090522
FILED AS OF DATE:		20090526
DATE AS OF CHANGE:		20090526

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gulfo Joseph V
		CENTRAL INDEX KEY:			0001335491

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51481
		FILM NUMBER:		09851843

	MAIL ADDRESS:	
		STREET 1:		1 BRIDGE STREET
		CITY:			IRVINGTON
		STATE:			NY
		ZIP:			10533

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ELECTRO OPTICAL SCIENCES INC /NY
		CENTRAL INDEX KEY:			0001051514
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				133986004

	BUSINESS ADDRESS:	
		STREET 1:		3 WEST MAIN STREET, SUITE 201
		CITY:			IRVINGTON
		STATE:			NY
		ZIP:			10533
		BUSINESS PHONE:		914-591-3783

	MAIL ADDRESS:	
		STREET 1:		3 WEST MAIN STREET, SUITE 201
		CITY:			IRVINGTON
		STATE:			NY
		ZIP:			10533
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2009-05-22</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001051514</issuerCik>
        <issuerName>ELECTRO OPTICAL SCIENCES INC /NY</issuerName>
        <issuerTradingSymbol>MELA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001335491</rptOwnerCik>
            <rptOwnerName>Gulfo Joseph V</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ELECTRO-OPTICAL SCIENCES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>3 WEST MAIN ST.  SUITE #201</rptOwnerStreet2>
            <rptOwnerCity>IRVINGTON</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10533</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>CEO &amp; President</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Option</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.75</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2008-10-10</value>
            </transactionDate>
            <deemedExecutionDate>
                <value>2009-05-22</value>
            </deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>180000</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>3.75</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2009-10-10</value>
            </exerciseDate>
            <expirationDate>
                <value>2018-10-10</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>180000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>180000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">On October 10, 2008, Dr. Gulfo was granted stock options for 900,000 shares of the Issuer's common stock. These shares have an exercise price of $3.75 per share, which was the current market price at the date of the grant. This grant vests as follows: (i) with respect to 180,000 shares, immediately (the &quot;Vested Shares&quot;); (ii) with respect to 540,000 shares, upon the Issuer receiving approval from the Food and Drug Administration for a pre-market approval application for MelaFind; and (iii) with respect to 180,000 shares, in four equal annual installments commencing on October 10, 2009 (the &quot;Annual Shares&quot;). The Annual Shares were issued subject to stockholder approval, which was obtained at the Issuer's Annual Meeting held on May 22, 2009, and accordingly are now being reported in this Form 4. The Vested Shares were previously reported in a Form 4 filed with the SEC on October 15, 2008.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Philip DeBellis as attorney-in-fact for Joseph V. Gulfo</signatureName>
        <signatureDate>2009-05-26</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
